Landos Biopharma, Inc. Current Ratio 2021-2024 | LABP
Landos Biopharma, Inc. current ratio from 2021 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-03-31 | $0.03B | $0.01B | 4.43 |
| 2023-12-31 | $0.04B | $0.01B | 6.09 |
| 2023-09-30 | $0.04B | $0.01B | 7.77 |
| 2023-06-30 | $0.05B | $0.00B | 15.35 |
| 2023-03-31 | $0.05B | $0.00B | 12.30 |
| 2022-12-31 | $0.05B | $0.01B | 7.39 |
| 2022-09-30 | $0.05B | $0.01B | 9.04 |
| 2022-06-30 | $0.06B | $0.01B | 8.92 |
| 2022-03-31 | $0.08B | $0.02B | 4.99 |
| 2021-12-31 | $0.09B | $0.02B | 5.55 |
| 2021-09-30 | $0.10B | $0.01B | 9.40 |
| 2021-06-30 | $0.12B | $0.01B | 9.40 |
| 2021-03-31 | $0.11B | $0.01B | 12.44 |
| 2020-12-31 | $0.03B | $0.01B | 2.71 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
